Biblio Discovery — Demo Discovery Service

78 results

Showing 1–20 · 0.07 seconds · RSS

Journal

European Medical Journal Hepatology (2026)

ISSN 2053-4221 · European Medical Journal · 78 articles in the index

  1. Journal Article

    Clinical Outcomes of Cross-Sectional Imaging to Investigate Hepatic Focal Fatty Sparing in Patients with Advanced Chronic Liver Disease

    Caterina Prada; Laurence Vaitiekunas; Maria Reyes et al.

    European Medical Journal Hepatology (2026) · 2026 · English · DOAJ

    Background: Focal fatty sparing (FFS) is a benign, localised absence of hepatic fat in an otherwise steatotic liver, frequently identified on surveillance liver ultrasound in patients with advanced chronic liver disease (ACLD). However, FFS can mimic hepatocellular carcinoma (HCC), and may prompt…

  2. Journal Article

    Tongue Hyperpigmentation with Peginterferon α-2b Therapy in Hepatitis B: Case Series With Review of Literature

    Saubhik Ghosh; Tryambak Samanta

    European Medical Journal Hepatology (2024) · 2024 · English · DOAJ

    Peginterferon α-2b (Peg IFNα-2b) continues to be used for treating a selected subset of patients with hepatitis B, in the era of direct-acting antivirals for hepatitis C infection. The authors hereby report four cases of tongue pigmentation among 21 patients with hepatitis B, whom they treated in…

  3. Journal Article

    Management of Clinically Significant Itch in Cholestatic Liver Disease

    Cynthia Levy; Gideon Hirschfield; Andreas Kremer et al.

    European Medical Journal Hepatology (2023) · 2023 · English · DOAJ

    Cholestatic liver diseases include primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and progressive familial intrahepatic cholestasis (PFIC). In all of these conditions, cholestatic itch is a major symptom that can severely and chronically impact a person’s quality of life…

  4. Journal Article

    Non-alcoholic Steatohepatitis: Global Impact and Clinical Consequences

    Zobair Younossi; Linda Henry

    European Medical Journal Hepatology, Pp 74-83 (2022) · 2022 · English · DOAJ

    Non-alcoholic steatohepatitis (NASH) is the potentially progressive form of non-alcoholic fatty liver disease (NAFLD). NAFLD and NASH are very common in most regions of the world and are on trajectory to become the most common liver disease at a global scale. Risk for high prevalence and…

  5. Journal Article

    Post-traumatic Isolated Right Hepatic Duct Injury: A Case Report

    Harshit Arora; Waryaam Singh; Vasudha Sharma et al.

    European Medical Journal Hepatology, Pp 81-86 (2022) · 2022 · English · DOAJ

    A 73-year-old female presented with a rare presentation of extrahepatic ductal injuries post-trauma in the form of a right hepatic duct injury. Such injuries go undetected despite normally advised imaging, presenting a few to several days post-trauma. Taking into consideration the risk of biliary…

  6. Journal Article

    Paediatric Acute-on-Chronic Liver Failure: A Review of Current Evidence in Children

    Lynette Go; Fang Kuan Chiou

    European Medical Journal Hepatology, Pp 64-73 (2022) · 2022 · English · DOAJ

    Acute-on-chronic liver failure (ACLF) is a syndrome that describes acute decompensation of chronic liver disease with differing definitions worldwide, but is universally associated with high short-term mortality. This is becoming increasingly recognised as a unique entity that affects both adults…

  7. Journal Article

    Primary Sclerosing Cholangitis in a Paediatric Patient: An Atypical Presentation

    Maryam Haider; Abdalaziz Awadelkarim; Huyam Awadalla et al.

    European Medical Journal Hepatology (2022) · 2022 · English · DOAJ

    Primary sclerosing cholangitis (PSC) is an autoimmune chronic liver disease that studies have shown is rare in children. Here, a challenging case of PSC in a 13-year-old male, without preceding manifestations of inflammatory bowel disease and with evidence of biliary obstruction, is reported. The…

  8. Journal Article

    The Challenging Ethical Landscape of Non-alcoholic Fatty Liver Disease

    Philip Berry; Sreelakshmi Kotha

    European Medical Journal Hepatology (2022) · 2022 · English · DOAJ

    Non-alcoholic fatty liver disease presents a number of ethical dilemmas. These relate to the potential harms of diagnosing the disease in health, diagnosing a condition for which there is no effective treatment, and variability in specialists’ attitudes to discussing and managing obesity. Erroneous…

  9. Journal Article

    Frequency Distribution of Hepatitis C Virus Genotypes with Reference to Age and Sex in Various Districts of Khyber Pakhtunkhwa, Pakistan

    Bakht Biland; Mohsina Haq; Sardar Muhammad et al.

    European Medical Journal Hepatology, Pp 83-88 (2021) · 2021 · English · DOAJ

    Background: Pakistan has the second highest prevalence of hepatitis C in the world after Egypt. Viral hepatitis is a leading cause of morbidity and mortality in Pakistan and, worryingly, reinfection rates are also on the rise. This cross-sectional study was aimed at finding the most common…

  10. Journal Article

    Hepatic Encephalopathy: A Review

    Savan Kabaria; Ishita Dalal; Kapil Gupta et al.

    European Medical Journal Hepatology, Pp 89-97 (2021) · 2021 · English · DOAJ

    Hepatic encephalopathy (HE) is a reversible syndrome observed in patients with liver disease. The syndrome is characterised by a spectrum of neuropsychiatric abnormalities resulting from the accumulation of neurotoxic substances in the bloodstream and ultimately in the brain. HE is a huge burden to…

  11. Journal Article

    Elevated Glucagon in a Patient with Necrolytic Acral Erythema: A Case Report and Review of the Literature

    Jenna E Koblinski; Blake W Traube; Margaret Kessler et al.

    European Medical Journal Hepatology, Pp 47-56 (2021) · 2021 · English · DOAJ

    Necrolytic acral erythema (NAE) is a relatively newly described dermatologic disease that is often associated with hepatitis C virus (HCV). Oral zinc therapy is a successful treatment; however, therapy is often delayed due to misdiagnosis. There are limited reports of NAE in the literature. This…

  12. Journal Article

    Difficult Biliary Cannulation in Endoscopic Retrograde Cholangiopancreatography: Definitions, Risk Factors, and Implications

    Brian M. Fung; Teodor C. Pitea; James H. Tabibian

    European Medical Journal Hepatology, Pp 64-72 (2021) · 2021 · English · DOAJ

    Over the past 50 years, endoscopic retrograde cholangiopancreatography (ERCP) has become the preferred minimally invasive method of treating a vast array of pancreatobiliary diseases. An initial sine qua non for ERCP success is selective ductal cannulation. Despite significant progress in the…

  13. Journal Article

    Difficult Biliary Cannulation in Endoscopic Retrograde Cholangiopancreatography: An Overview of Advanced Techniques

    Brian M. Fung; Teodor C. Pitea; James H. Tabibian

    European Medical Journal Hepatology, Pp 73-82 (2021) · 2021 · English · DOAJ

    Endoscopic retrograde cholangiopancreatography (ERCP) plays a significant role in the treatment of a vast array of pancreatobiliary diseases. However, despite significant progress in the optimisation of ERCP methods and accessories, the technical and clinical success of ERCP can vary significantly…

  14. Journal Article

    Targeting Raised von Willebrand Factor Levels in Liver Diseases: Opening Up Newer Therapeutic Avenues

    Ashish Goel; Sukesh C. Nair; Uday Zachariah et al.

    European Medical Journal Hepatology, Vol. 8 No. 1 · 2020 · English · DOAJ

    Raised levels of the blood coagulation protein von Willebrand factor (VWF) are now recognised to be important in patients with liver disease. The markedly raised plasma VWF levels in patients with acute liver failure and acute-on-chronic liver failure may contribute to the pathogenesis of liver…

  15. Journal Article

    Cholangioscopy and its Role in Primary Sclerosing Cholangitis

    Brian M. Fung; M. Phillip Fejleh; Sooraj Tejaswi et al.

    European Medical Journal Hepatology, Vol. 8 No. 1 · 2020 · English · DOAJ

    Primary sclerosing cholangitis (PSC) is a cholestatic liver disease characterised by chronic inflammation and fibro-obliteration of the intrahepatic and/or extrahepatic bile ducts. It is associated with numerous hepatobiliary complications including an increased risk of malignancy (in particular…